Your browser doesn't support javascript.
loading
Esketamine and the Need for a New Type of Registry for Drugs With Abuse Potential.
McShane, Rupert; Baldwin, David S; McAllister-Williams, R Hamish; Stone, James M; Taylor, David; Winstock, Adam R; Young, Allan H.
Afiliación
  • McShane R; Department of Psychiatry, University of Oxford, and Oxford Health NHS Foundation Trust, Oxford, U.K. (McShane); Department of Psychiatry and Pharmacology, University of Southampton, Southampton, U.K. (Baldwin); Department of Neurodegenerative, Cerebrovascular, and Psychiatric Disorders, Institute of
  • Baldwin DS; Department of Psychiatry, University of Oxford, and Oxford Health NHS Foundation Trust, Oxford, U.K. (McShane); Department of Psychiatry and Pharmacology, University of Southampton, Southampton, U.K. (Baldwin); Department of Neurodegenerative, Cerebrovascular, and Psychiatric Disorders, Institute of
  • McAllister-Williams RH; Department of Psychiatry, University of Oxford, and Oxford Health NHS Foundation Trust, Oxford, U.K. (McShane); Department of Psychiatry and Pharmacology, University of Southampton, Southampton, U.K. (Baldwin); Department of Neurodegenerative, Cerebrovascular, and Psychiatric Disorders, Institute of
  • Stone JM; Department of Psychiatry, University of Oxford, and Oxford Health NHS Foundation Trust, Oxford, U.K. (McShane); Department of Psychiatry and Pharmacology, University of Southampton, Southampton, U.K. (Baldwin); Department of Neurodegenerative, Cerebrovascular, and Psychiatric Disorders, Institute of
  • Taylor D; Department of Psychiatry, University of Oxford, and Oxford Health NHS Foundation Trust, Oxford, U.K. (McShane); Department of Psychiatry and Pharmacology, University of Southampton, Southampton, U.K. (Baldwin); Department of Neurodegenerative, Cerebrovascular, and Psychiatric Disorders, Institute of
  • Winstock AR; Department of Psychiatry, University of Oxford, and Oxford Health NHS Foundation Trust, Oxford, U.K. (McShane); Department of Psychiatry and Pharmacology, University of Southampton, Southampton, U.K. (Baldwin); Department of Neurodegenerative, Cerebrovascular, and Psychiatric Disorders, Institute of
  • Young AH; Department of Psychiatry, University of Oxford, and Oxford Health NHS Foundation Trust, Oxford, U.K. (McShane); Department of Psychiatry and Pharmacology, University of Southampton, Southampton, U.K. (Baldwin); Department of Neurodegenerative, Cerebrovascular, and Psychiatric Disorders, Institute of
Am J Psychiatry ; 176(11): 966, 2019 11 01.
Article en En | MEDLINE | ID: mdl-31672039
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Suicidio / Depresión Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Am J Psychiatry Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Suicidio / Depresión Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Am J Psychiatry Año: 2019 Tipo del documento: Article